$9.07
-0.17[-1.84%]
At close: Apr 24
$9.07
0[0.00%]
After Hours: 4:00PM EDT
Fennec Pharmaceuticals
(NASDAQ:FENC)Fennec Pharmaceuticals Stock (NASDAQ:FENC), Analyst Ratings, Price Targets, Predictions
Fennec Pharmaceuticals Inc has a consensus price target of $15.67, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Craig-Hallum, and HC Wainwright & Co. on April 4, 2024, March 18, 2024, and August 4, 2023. With an average price target of $17.67 between HC Wainwright & Co., Craig-Hallum, and HC Wainwright & Co., there's an implied 94.78% upside for Fennec Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Cantor Fitzgerald
Cantor Fitzgerald
Wedbush
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Fennec Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | $17 → $18 | Maintains | Buy | Get Alert |
| 03/18/2024 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | Craig-Hallum | Chase Knickerbocker | $17 → $18 | Maintains | Buy | Get Alert |
| 08/04/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 87.43% | HC Wainwright & Co. | Raghuram Selvaraju | $18 → $17 | Maintains | Buy | Get Alert |
| 06/21/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/06/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 76.41% | Cantor Fitzgerald | Charles Robertson II | $12 → $16 | Maintains | Overweight | Get Alert |
| 04/04/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 11/22/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 32.3% | Cantor Fitzgerald | Charles Duncan | $9 → $12 | Upgrade | Neutral → Overweight | Get Alert |
| 10/20/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 98.46% | HC Wainwright & Co. | Raghuram Selvaraju | $14 → $18 | Maintains | Buy | Get Alert |
| 09/26/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 109.48% | Wedbush | David Nierengarten | $11 → $19 | Maintains | Outperform | Get Alert |
| 09/07/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 21.28% | Capital One | Naureen Quibria | → $11 | Initiates | → Overweight | Get Alert |
| 08/08/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 54.36% | Craig-Hallum | Chase Knickerbocker | → $14 | Assumes | → Buy | Get Alert |
| 06/03/2021 | FENC | Buy Now | Fennec Pharmaceuticals | $9.07 | 54.36% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Fennec Pharmaceuticals (FENC)?
The latest price target for Fennec Pharmaceuticals (NASDAQ: FENC) was reported by HC Wainwright & Co. on April 4, 2024. The analyst firm set a price target for $18.00 expecting FENC to rise to within 12 months (a possible 98.46% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?
The latest analyst rating for Fennec Pharmaceuticals (NASDAQ: FENC) was provided by HC Wainwright & Co., and Fennec Pharmaceuticals maintained their buy rating.
When was the last upgrade for Fennec Pharmaceuticals (FENC)?
The last upgrade for Fennec Pharmaceuticals Inc happened on November 22, 2022 when Cantor Fitzgerald raised their price target to $12. Cantor Fitzgerald previously had a neutral for Fennec Pharmaceuticals Inc.
When was the last downgrade for Fennec Pharmaceuticals (FENC)?
There is no last downgrade for Fennec Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?
While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a maintained with a price target of $17.00 to $18.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $9.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.